Skip to main content
Top

25-04-2024 | Human Immunodeficiency Virus | Original Paper

Prevalence and Correlates of Heavy Alcohol use among People Living with HIV who use Unregulated Drugs in Vancouver, Canada

Authors: Jeremy Hui, Hudson Reddon, Nadia Fairbairn, JinCheol Choi, M-J Milloy, Maria Eugenia Socias

Published in: AIDS and Behavior

Login to get access

Abstract

Among people living with HIV (PLWH), heavy alcohol use is associated with many negative health consequences. However, the impacts of heavy alcohol use are not well described for PLWH who use drugs. Thus, we investigated the prevalence and correlates of heavy alcohol use among a cohort of people who use drugs (PWUD) living with HIV in Vancouver, Canada. We accessed data from an ongoing community-recruited prospective cohort of PLWH who use drugs with linked comprehensive HIV clinical monitoring data. We used generalized linear mixed-effects modeling to identify factors longitudinally associated with periods of heavy alcohol use between December 2005 and December 2019. Of the 896 participants included, 291 (32.5%) reported at least one period with heavy alcohol use. Periods of recent incarceration (Adjusted Odds Ratio [AOR] = 1.48, 95% Confidence Interval [CI]: 1.01–2.17), encounters with police (AOR = 1.87, 95% CI: 1.37–2.56), and older age (AOR = 1.05, 95% CI: 1.02–1.07) were positively associated with heavy alcohol use. Engagement in drug or alcohol treatment (AOR = 0.54, 95% CI: 0.42–0.70) and male gender (AOR = 0.46; 95% CI: 0.27–0.78) were negatively associated with heavy alcohol use. We observed that heavy alcohol use was clearly linked to involvement with the criminal justice system. These findings, together with the protective effects of substance use treatment, suggest the need to expand access for drug and alcohol treatment programs overall, and in particular through the criminal justice system to reduce alcohol-related harms among PLWH who use drugs.
Literature
1.
go back to reference GBD 2016 Alcohol Collaborators. Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet. 2018;392:1015–35.PubMedCentralCrossRef GBD 2016 Alcohol Collaborators. Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet. 2018;392:1015–35.PubMedCentralCrossRef
2.
go back to reference Giordano TP, Visnegarwala F, White AC, Troisi CL, Frankowski RF, Hartman CM, et al. Patients referred to an urban HIV clinic frequently fail to establish care: factors predicting failure. AIDS Care. 2005;17:773–83.PubMedCrossRef Giordano TP, Visnegarwala F, White AC, Troisi CL, Frankowski RF, Hartman CM, et al. Patients referred to an urban HIV clinic frequently fail to establish care: factors predicting failure. AIDS Care. 2005;17:773–83.PubMedCrossRef
3.
go back to reference Amirkhanian YA, Kelly JA, DiFranceisco WJ, Kuznetsova AV, Tarima SS, Yakovlev AA, et al. Predictors of HIV Care Engagement, antiretroviral medication adherence, and viral suppression among people living with HIV infection in St. Petersburg, Russia. AIDS Behav. 2018;22:791–9.PubMedPubMedCentralCrossRef Amirkhanian YA, Kelly JA, DiFranceisco WJ, Kuznetsova AV, Tarima SS, Yakovlev AA, et al. Predictors of HIV Care Engagement, antiretroviral medication adherence, and viral suppression among people living with HIV infection in St. Petersburg, Russia. AIDS Behav. 2018;22:791–9.PubMedPubMedCentralCrossRef
4.
go back to reference Hendershot CS, Stoner SA, Pantalone DW, Simoni JM. Alcohol use and antiretroviral adherence: review and meta-analysis. J Acquir Immune Defic Syndr. 2009;52:180–202.PubMedPubMedCentralCrossRef Hendershot CS, Stoner SA, Pantalone DW, Simoni JM. Alcohol use and antiretroviral adherence: review and meta-analysis. J Acquir Immune Defic Syndr. 2009;52:180–202.PubMedPubMedCentralCrossRef
5.
go back to reference Chander G, Lau B, Moore RD. Hazardous alcohol use: a risk factor for non-adherence and lack of suppression in HIV infection. J Acquir Immune Defic Syndr. 2006;43:411–7.PubMedPubMedCentralCrossRef Chander G, Lau B, Moore RD. Hazardous alcohol use: a risk factor for non-adherence and lack of suppression in HIV infection. J Acquir Immune Defic Syndr. 2006;43:411–7.PubMedPubMedCentralCrossRef
6.
8.
go back to reference Marshall BDL, Tate JP, McGinnis KA, Bryant KJ, Cook RL, Edelman EJ, et al. Long-term alcohol use patterns and HIV disease severity. AIDS. 2017;31:1313–21.PubMedCrossRef Marshall BDL, Tate JP, McGinnis KA, Bryant KJ, Cook RL, Edelman EJ, et al. Long-term alcohol use patterns and HIV disease severity. AIDS. 2017;31:1313–21.PubMedCrossRef
9.
go back to reference Stein MD, Hanna L, Natarajan R, Clarke J, Marisi M, Sobota M, et al. Alcohol use patterns predict high-risk HIV behaviors among active injection drug users. J Subst Abuse Treat. 2000;18:359–63.PubMedCrossRef Stein MD, Hanna L, Natarajan R, Clarke J, Marisi M, Sobota M, et al. Alcohol use patterns predict high-risk HIV behaviors among active injection drug users. J Subst Abuse Treat. 2000;18:359–63.PubMedCrossRef
10.
go back to reference Arasteh K, Des Jarlais DC. At-risk drinking and injection and sexual risk behaviors of HIV-positive injection drug users entering drug treatment in New York City. AIDS Patient Care STDS. 2009;23:657–61.PubMedPubMedCentralCrossRef Arasteh K, Des Jarlais DC. At-risk drinking and injection and sexual risk behaviors of HIV-positive injection drug users entering drug treatment in New York City. AIDS Patient Care STDS. 2009;23:657–61.PubMedPubMedCentralCrossRef
11.
go back to reference Le Marchand C, Evans J, Page K, Davidson PJ, Hahn JA. Hazardous alcohol consumption among young adult IDU and its association with high risk behaviors. Drug Alcohol Depend. 2013;127:143–9.PubMedCrossRef Le Marchand C, Evans J, Page K, Davidson PJ, Hahn JA. Hazardous alcohol consumption among young adult IDU and its association with high risk behaviors. Drug Alcohol Depend. 2013;127:143–9.PubMedCrossRef
12.
go back to reference Fairbairn N, Wood E, Dong H, Kerr T, DeBeck K. Unsafe sexual behaviour associated with hazardous alcohol use among street-involved youth. AIDS Care. 2017;29:481–8.PubMedCrossRef Fairbairn N, Wood E, Dong H, Kerr T, DeBeck K. Unsafe sexual behaviour associated with hazardous alcohol use among street-involved youth. AIDS Care. 2017;29:481–8.PubMedCrossRef
13.
go back to reference Fairbairn N, Hayashi K, Milloy M-J, Nolan S, Nguyen P, Wood E, et al. Hazardous alcohol use associated with increased sexual risk behaviors among people who inject drugs. Alcohol Clin Exp Res. 2016;40:2394–400.PubMedPubMedCentralCrossRef Fairbairn N, Hayashi K, Milloy M-J, Nolan S, Nguyen P, Wood E, et al. Hazardous alcohol use associated with increased sexual risk behaviors among people who inject drugs. Alcohol Clin Exp Res. 2016;40:2394–400.PubMedPubMedCentralCrossRef
14.
go back to reference Marshall BDL, Fairbairn N, Li K, Wood E, Kerr T. Physical violence among a prospective cohort of injection drug users: a gender-focused approach. Drug Alcohol Depend. 2008;97:237–46.PubMedPubMedCentralCrossRef Marshall BDL, Fairbairn N, Li K, Wood E, Kerr T. Physical violence among a prospective cohort of injection drug users: a gender-focused approach. Drug Alcohol Depend. 2008;97:237–46.PubMedPubMedCentralCrossRef
15.
go back to reference Dietze P, Jenkinson R, Aitken C, Stoové M, Jolley D, Hickman M, et al. The relationship between alcohol use and injecting drug use: impacts on health, crime and wellbeing. Drug Alcohol Depend. 2013;128:111–5.PubMedCrossRef Dietze P, Jenkinson R, Aitken C, Stoové M, Jolley D, Hickman M, et al. The relationship between alcohol use and injecting drug use: impacts on health, crime and wellbeing. Drug Alcohol Depend. 2013;128:111–5.PubMedCrossRef
16.
go back to reference Klimas J, Nosova E, Socías E, Nolan S, Brar R, Hayashi K, et al. Factors associated with discontinuation of methadone maintenance therapy (MMT) among persons who use alcohol in Vancouver, Canada. Drug Alcohol Depend. 2018;186:182–6.PubMedPubMedCentralCrossRef Klimas J, Nosova E, Socías E, Nolan S, Brar R, Hayashi K, et al. Factors associated with discontinuation of methadone maintenance therapy (MMT) among persons who use alcohol in Vancouver, Canada. Drug Alcohol Depend. 2018;186:182–6.PubMedPubMedCentralCrossRef
17.
go back to reference Young SV, Wood E, Dong H, Kerr T, Hayashi K. Daily alcohol use as an independent risk factor for HIV seroconversion among people who inject drugs. Addiction. 2016;111:1360–5.PubMedPubMedCentralCrossRef Young SV, Wood E, Dong H, Kerr T, Hayashi K. Daily alcohol use as an independent risk factor for HIV seroconversion among people who inject drugs. Addiction. 2016;111:1360–5.PubMedPubMedCentralCrossRef
18.
go back to reference Johnson C, Dong H, Ahamad K, Hayashi K, Milloy MJ, Kerr T, et al. Impact of binge alcohol on mortality among people who inject drugs. Addict Behav Rep. 2015;2:28–32.PubMedPubMedCentral Johnson C, Dong H, Ahamad K, Hayashi K, Milloy MJ, Kerr T, et al. Impact of binge alcohol on mortality among people who inject drugs. Addict Behav Rep. 2015;2:28–32.PubMedPubMedCentral
19.
go back to reference Palepu A, Tyndall MW, Li K, Yip B, O’Shaughnessy MV, Schechter MT, et al. Alcohol use and incarceration adversely affect HIV-1 RNA suppression among injection drug users starting antiretroviral therapy. J Urban Health. 2003;80:667–75.PubMedPubMedCentralCrossRef Palepu A, Tyndall MW, Li K, Yip B, O’Shaughnessy MV, Schechter MT, et al. Alcohol use and incarceration adversely affect HIV-1 RNA suppression among injection drug users starting antiretroviral therapy. J Urban Health. 2003;80:667–75.PubMedPubMedCentralCrossRef
20.
go back to reference Fairbairn NS, Walley AY, Cheng DM, Quinn E, Bridden C, Chaisson C, et al. Mortality in HIV-Infected alcohol and drug users in St. Petersburg, Russia. PLoS ONE. 2016;11:e0166539.PubMedPubMedCentralCrossRef Fairbairn NS, Walley AY, Cheng DM, Quinn E, Bridden C, Chaisson C, et al. Mortality in HIV-Infected alcohol and drug users in St. Petersburg, Russia. PLoS ONE. 2016;11:e0166539.PubMedPubMedCentralCrossRef
21.
go back to reference Khan MR, McGinnis KA, Grov C, Scheidell JD, Hawks L, Edelman EJ, et al. Past year and prior incarceration and HIV transmission risk among HIV-positive men who have sex with men in the US. AIDS Care. 2019;31:349–56.PubMedCrossRef Khan MR, McGinnis KA, Grov C, Scheidell JD, Hawks L, Edelman EJ, et al. Past year and prior incarceration and HIV transmission risk among HIV-positive men who have sex with men in the US. AIDS Care. 2019;31:349–56.PubMedCrossRef
22.
go back to reference Bazzi AR, Drainoni M-L, Biancarelli DL, Hartman JJ, Mimiaga MJ, Mayer KH, et al. Systematic review of HIV treatment adherence research among people who inject drugs in the United States and Canada: evidence to inform pre-exposure prophylaxis (PrEP) adherence interventions. BMC Public Health. 2019;19:31.PubMedPubMedCentralCrossRef Bazzi AR, Drainoni M-L, Biancarelli DL, Hartman JJ, Mimiaga MJ, Mayer KH, et al. Systematic review of HIV treatment adherence research among people who inject drugs in the United States and Canada: evidence to inform pre-exposure prophylaxis (PrEP) adherence interventions. BMC Public Health. 2019;19:31.PubMedPubMedCentralCrossRef
23.
go back to reference Wang EA, McGinnis KA, Long JB, Akgün KM, Edelman EJ, Rimland D, et al. Incarceration and health outcomes in HIV-infected patients: the impact of substance use, primary care engagement, and antiretroviral adherence. Am J Addict. 2015;24:178–84.PubMedPubMedCentralCrossRef Wang EA, McGinnis KA, Long JB, Akgün KM, Edelman EJ, Rimland D, et al. Incarceration and health outcomes in HIV-infected patients: the impact of substance use, primary care engagement, and antiretroviral adherence. Am J Addict. 2015;24:178–84.PubMedPubMedCentralCrossRef
25.
go back to reference Small W, Maher L, Lawlor J, Wood E, Shannon K, Kerr T. Injection drug users’ involvement in drug dealing in the downtown eastside of Vancouver: social organization and systemic violence. Int J Drug Policy. 2013;24:479–87.PubMedPubMedCentralCrossRef Small W, Maher L, Lawlor J, Wood E, Shannon K, Kerr T. Injection drug users’ involvement in drug dealing in the downtown eastside of Vancouver: social organization and systemic violence. Int J Drug Policy. 2013;24:479–87.PubMedPubMedCentralCrossRef
26.
go back to reference Linden IA, Mar MY, Werker GR, Jang K, Krausz M. Research on a vulnerable neighborhood-the Vancouver downtown eastside from 2001 to 2011. J Urban Health. 2013;90:559–73.PubMedCrossRef Linden IA, Mar MY, Werker GR, Jang K, Krausz M. Research on a vulnerable neighborhood-the Vancouver downtown eastside from 2001 to 2011. J Urban Health. 2013;90:559–73.PubMedCrossRef
27.
go back to reference Burnett K. Commodifying poverty: gentrification and consumption in Vancouver’s downtown Eastside. Urban Geogr. 2014;35:157–76.CrossRef Burnett K. Commodifying poverty: gentrification and consumption in Vancouver’s downtown Eastside. Urban Geogr. 2014;35:157–76.CrossRef
28.
go back to reference Wood E, Hogg RS, Lima VD, Kerr T, Yip B, Marshall BDL, et al. Highly active antiretroviral therapy and survival in HIV-infected injection drug users. JAMA. 2008;300:550–4.PubMedCrossRef Wood E, Hogg RS, Lima VD, Kerr T, Yip B, Marshall BDL, et al. Highly active antiretroviral therapy and survival in HIV-infected injection drug users. JAMA. 2008;300:550–4.PubMedCrossRef
31.
32.
go back to reference Crabb DW, Im GY, Szabo G, Mellinger JL, Lucey MR. Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American association for the study of liver diseases. Hepatology. 2020;71:306–33.PubMedCrossRef Crabb DW, Im GY, Szabo G, Mellinger JL, Lucey MR. Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American association for the study of liver diseases. Hepatology. 2020;71:306–33.PubMedCrossRef
33.
go back to reference Piano MR, Mazzuco A, Kang M, Phillips SA. Cardiovascular consequences of binge drinking: an integrative review with implications for advocacy, policy, and research. Alcohol Clin Exp Res. 2017;41:487–96.PubMedPubMedCentralCrossRef Piano MR, Mazzuco A, Kang M, Phillips SA. Cardiovascular consequences of binge drinking: an integrative review with implications for advocacy, policy, and research. Alcohol Clin Exp Res. 2017;41:487–96.PubMedPubMedCentralCrossRef
34.
go back to reference Prangnell A, Nosova E, Milloy M-J, Wood E, Hayashi K. The relationship between parental heavy drinking and non-fatal overdose among people who inject drugs in Vancouver, Canada. Addict Behav. 2019;89:224–8.PubMedCrossRef Prangnell A, Nosova E, Milloy M-J, Wood E, Hayashi K. The relationship between parental heavy drinking and non-fatal overdose among people who inject drugs in Vancouver, Canada. Addict Behav. 2019;89:224–8.PubMedCrossRef
35.
go back to reference Klimas J, Wood E, Nguyen P, Dong H, Milloy MJ, Kerr T, et al. The impact of Enrolment in methadone maintenance therapy on initiation of heavy drinking among people who use Heroin. Eur Addict Res. 2016;22:210–4.PubMedCrossRef Klimas J, Wood E, Nguyen P, Dong H, Milloy MJ, Kerr T, et al. The impact of Enrolment in methadone maintenance therapy on initiation of heavy drinking among people who use Heroin. Eur Addict Res. 2016;22:210–4.PubMedCrossRef
36.
go back to reference Socías ME, Wood E, Kerr T, Nolan S, Hayashi K, Nosova E et al. Trends in engagement in the cascade of care for opioid use disorder, Vancouver, Canada, 2006–2016. Drug Alcohol Depend. 2018;189:90–5. Socías ME, Wood E, Kerr T, Nolan S, Hayashi K, Nosova E et al. Trends in engagement in the cascade of care for opioid use disorder, Vancouver, Canada, 2006–2016. Drug Alcohol Depend. 2018;189:90–5.
37.
go back to reference Liang J, Nosova E, Reddon H, Nolan S, Socías E, Barrios R, et al. Longitudinal patterns of illicit drug use, antiretroviral therapy exposure and plasma HIV-1 RNA viral load among HIV-positive people who use illicit drugs. AIDS. 2020;34:1389–96.PubMedCrossRef Liang J, Nosova E, Reddon H, Nolan S, Socías E, Barrios R, et al. Longitudinal patterns of illicit drug use, antiretroviral therapy exposure and plasma HIV-1 RNA viral load among HIV-positive people who use illicit drugs. AIDS. 2020;34:1389–96.PubMedCrossRef
38.
go back to reference Ladak F, Socias E, Nolan S, Dong H, Kerr T, Wood E, et al. Substance use patterns and HIV-1 RNA viral load rebound among HIV-positive illicit drug users in a Canadian setting. Antivir Ther. 2019;24:19–25.PubMedPubMedCentralCrossRef Ladak F, Socias E, Nolan S, Dong H, Kerr T, Wood E, et al. Substance use patterns and HIV-1 RNA viral load rebound among HIV-positive illicit drug users in a Canadian setting. Antivir Ther. 2019;24:19–25.PubMedPubMedCentralCrossRef
39.
go back to reference Serdar CC, Cihan M, Yücel D, Serdar MA. Sample size, power and effect size revisited: simplified and practical approaches in pre-clinical, clinical and laboratory studies. Biochem Med (Zagreb). 2021;31:010502.PubMedCrossRef Serdar CC, Cihan M, Yücel D, Serdar MA. Sample size, power and effect size revisited: simplified and practical approaches in pre-clinical, clinical and laboratory studies. Biochem Med (Zagreb). 2021;31:010502.PubMedCrossRef
40.
go back to reference Reddon H, Fast D, DeBeck K, Werb D, Hayashi K, Wood E, et al. Prevalence and correlates of selling illicit cannabis among people who use drugs in Vancouver, Canada: a ten-year prospective cohort study. Int J Drug Policy. 2019;69:16–23.PubMedPubMedCentralCrossRef Reddon H, Fast D, DeBeck K, Werb D, Hayashi K, Wood E, et al. Prevalence and correlates of selling illicit cannabis among people who use drugs in Vancouver, Canada: a ten-year prospective cohort study. Int J Drug Policy. 2019;69:16–23.PubMedPubMedCentralCrossRef
41.
go back to reference Obradovic M, Lal A, Liedgens H. Validity and responsiveness of EuroQol-5 dimension (EQ-5D) versus short Form-6 dimension (SF-6D) questionnaire in chronic pain. Health Qual Life Outcomes. 2013;11:110.PubMedPubMedCentralCrossRef Obradovic M, Lal A, Liedgens H. Validity and responsiveness of EuroQol-5 dimension (EQ-5D) versus short Form-6 dimension (SF-6D) questionnaire in chronic pain. Health Qual Life Outcomes. 2013;11:110.PubMedPubMedCentralCrossRef
42.
go back to reference Tran BX, Dang AK, Truong NT, Ha GH, Nguyen HLT, Do HN, et al. Depression and quality of life among patients living with HIV/AIDS in the era of universal treatment access in Vietnam. Int J Environ Res Public Health. 2018;15:2888.PubMedPubMedCentralCrossRef Tran BX, Dang AK, Truong NT, Ha GH, Nguyen HLT, Do HN, et al. Depression and quality of life among patients living with HIV/AIDS in the era of universal treatment access in Vietnam. Int J Environ Res Public Health. 2018;15:2888.PubMedPubMedCentralCrossRef
43.
go back to reference Lake S, Walsh Z, Kerr T, Cooper ZD, Buxton J, Wood E, et al. Frequency of cannabis and illicit opioid use among people who use drugs and report chronic pain: a longitudinal analysis. PLoS Med. 2019;16:e1002967.PubMedPubMedCentralCrossRef Lake S, Walsh Z, Kerr T, Cooper ZD, Buxton J, Wood E, et al. Frequency of cannabis and illicit opioid use among people who use drugs and report chronic pain: a longitudinal analysis. PLoS Med. 2019;16:e1002967.PubMedPubMedCentralCrossRef
44.
go back to reference Sangsari S, Milloy M-J, Ibrahim A, Kerr T, Zhang R, Montaner J, et al. Physician experience and rates of plasma HIV-1 RNA suppression among illicit drug users: an observational study. BMC Infect Dis. 2012;12:22.PubMedPubMedCentralCrossRef Sangsari S, Milloy M-J, Ibrahim A, Kerr T, Zhang R, Montaner J, et al. Physician experience and rates of plasma HIV-1 RNA suppression among illicit drug users: an observational study. BMC Infect Dis. 2012;12:22.PubMedPubMedCentralCrossRef
45.
go back to reference Tapp C, Milloy M-J, Kerr T, Zhang R, Guillemi S, Hogg RS, et al. Female gender predicts lower access and adherence to antiretroviral therapy in a setting of free healthcare. BMC Infect Dis. 2011;11:86.PubMedPubMedCentralCrossRef Tapp C, Milloy M-J, Kerr T, Zhang R, Guillemi S, Hogg RS, et al. Female gender predicts lower access and adherence to antiretroviral therapy in a setting of free healthcare. BMC Infect Dis. 2011;11:86.PubMedPubMedCentralCrossRef
46.
go back to reference Fovet T, Wathelet M, Benbouriche M, Benradia I, Roelandt J-L, Thomas P, et al. Substance Use, Substance Use disorders, and Co-occurring Psychiatric disorders in recently incarcerated men: a comparison with the General Population. Eur Addict Res. 2022;28:368–76.PubMedCrossRef Fovet T, Wathelet M, Benbouriche M, Benradia I, Roelandt J-L, Thomas P, et al. Substance Use, Substance Use disorders, and Co-occurring Psychiatric disorders in recently incarcerated men: a comparison with the General Population. Eur Addict Res. 2022;28:368–76.PubMedCrossRef
47.
go back to reference Azbel L, Wickersham JA, Grishaev Y, Dvoryak S, Altice FL. Burden of infectious diseases, substance use disorders, and mental illness among Ukrainian prisoners transitioning to the community. PLoS ONE. 2013;8:e59643.PubMedPubMedCentralCrossRef Azbel L, Wickersham JA, Grishaev Y, Dvoryak S, Altice FL. Burden of infectious diseases, substance use disorders, and mental illness among Ukrainian prisoners transitioning to the community. PLoS ONE. 2013;8:e59643.PubMedPubMedCentralCrossRef
48.
go back to reference Binswanger IA, Stern MF, Deyo RA, Heagerty PJ, Cheadle A, Elmore JG, et al. Release from prison–a high risk of death for former inmates. N Engl J Med. 2007;356:157–65.PubMedPubMedCentralCrossRef Binswanger IA, Stern MF, Deyo RA, Heagerty PJ, Cheadle A, Elmore JG, et al. Release from prison–a high risk of death for former inmates. N Engl J Med. 2007;356:157–65.PubMedPubMedCentralCrossRef
49.
go back to reference Madkour AS, Felker-Kantor E, Welsh DA, Molina PE, Theall KP, Ferguson T. Lifetime Alcohol Use Trajectories and Health Status among persons living with HIV (PLWH). J Stud Alcohol Drugs. 2022;83:695–703.PubMedPubMedCentralCrossRef Madkour AS, Felker-Kantor E, Welsh DA, Molina PE, Theall KP, Ferguson T. Lifetime Alcohol Use Trajectories and Health Status among persons living with HIV (PLWH). J Stud Alcohol Drugs. 2022;83:695–703.PubMedPubMedCentralCrossRef
50.
go back to reference Seal DW, Eldrige GD, Kacanek D, Binson D, Macgowan RJ, Project START Study Group. A longitudinal, qualitative analysis of the context of substance use and sexual behavior among 18- to 29-year-old men after their release from prison. Soc Sci Med. 2007;65:2394–406.PubMedCrossRef Seal DW, Eldrige GD, Kacanek D, Binson D, Macgowan RJ, Project START Study Group. A longitudinal, qualitative analysis of the context of substance use and sexual behavior among 18- to 29-year-old men after their release from prison. Soc Sci Med. 2007;65:2394–406.PubMedCrossRef
51.
go back to reference English D, Carter JA, Bowleg L, Malebranche DJ, Talan AJ, Rendina HJ. Intersectional social control: the roles of incarceration and police discrimination in psychological and HIV-related outcomes for black sexual minority men. Soc Sci Med. 2020;258:113121.PubMedPubMedCentralCrossRef English D, Carter JA, Bowleg L, Malebranche DJ, Talan AJ, Rendina HJ. Intersectional social control: the roles of incarceration and police discrimination in psychological and HIV-related outcomes for black sexual minority men. Soc Sci Med. 2020;258:113121.PubMedPubMedCentralCrossRef
52.
go back to reference Beletsky L, Heller D, Jenness SM, Neaigus A, Gelpi-Acosta C, Hagan H. Syringe access, syringe sharing, and police encounters among people who inject drugs in New York City: a community-level perspective. Int J Drug Policy. 2014;25:105–11.PubMedCrossRef Beletsky L, Heller D, Jenness SM, Neaigus A, Gelpi-Acosta C, Hagan H. Syringe access, syringe sharing, and police encounters among people who inject drugs in New York City: a community-level perspective. Int J Drug Policy. 2014;25:105–11.PubMedCrossRef
53.
go back to reference Sørensen HJ, Manzardo A, Just-Østergaard E, Penick EC, Becker UMD, Mortensen EL, et al. Young adult predictors of alcohol dependence to age 53: a 44-year prospective cohort study of Danish men. Addiction. 2021;116:780–7.PubMedCrossRef Sørensen HJ, Manzardo A, Just-Østergaard E, Penick EC, Becker UMD, Mortensen EL, et al. Young adult predictors of alcohol dependence to age 53: a 44-year prospective cohort study of Danish men. Addiction. 2021;116:780–7.PubMedCrossRef
54.
go back to reference Jacob Arriola KR, Braithwaite RL, Holmes E, Fortenberry RM. Post-release case management services and health-seeking behavior among HIV-infected ex-offenders. J Health Care Poor Underserved. 2007;18:665–74.PubMedCrossRef Jacob Arriola KR, Braithwaite RL, Holmes E, Fortenberry RM. Post-release case management services and health-seeking behavior among HIV-infected ex-offenders. J Health Care Poor Underserved. 2007;18:665–74.PubMedCrossRef
55.
go back to reference Olgin GK, Bórquez A, Baker P, Clairgue E, Morales M, Bañuelos A, et al. Preferences and acceptability of law enforcement initiated referrals for people who inject drugs: a mixed methods analysis. Subst Abuse Treat Prev Policy. 2020;15:75.PubMedPubMedCentralCrossRef Olgin GK, Bórquez A, Baker P, Clairgue E, Morales M, Bañuelos A, et al. Preferences and acceptability of law enforcement initiated referrals for people who inject drugs: a mixed methods analysis. Subst Abuse Treat Prev Policy. 2020;15:75.PubMedPubMedCentralCrossRef
56.
go back to reference Go VF, Hutton HE, Ha TV, Chander G, Latkin CA, Mai NVT, et al. Effect of 2 Integrated Interventions on Alcohol Abstinence and viral suppression among Vietnamese adults with Hazardous Alcohol Use and HIV: a Randomized Clinical Trial. JAMA Netw Open. 2020;3:e2017115.PubMedPubMedCentralCrossRef Go VF, Hutton HE, Ha TV, Chander G, Latkin CA, Mai NVT, et al. Effect of 2 Integrated Interventions on Alcohol Abstinence and viral suppression among Vietnamese adults with Hazardous Alcohol Use and HIV: a Randomized Clinical Trial. JAMA Netw Open. 2020;3:e2017115.PubMedPubMedCentralCrossRef
57.
go back to reference Springer SA, Di Paola A, Barbour R, Azar MM, Altice FL. Extended-release Naltrexone improves viral suppression among incarcerated persons living with HIV and Alcohol use disorders transitioning to the community: results from a Double-Blind, placebo-controlled trial. J Acquir Immune Defic Syndr. 2018;79:92–100.PubMedPubMedCentralCrossRef Springer SA, Di Paola A, Barbour R, Azar MM, Altice FL. Extended-release Naltrexone improves viral suppression among incarcerated persons living with HIV and Alcohol use disorders transitioning to the community: results from a Double-Blind, placebo-controlled trial. J Acquir Immune Defic Syndr. 2018;79:92–100.PubMedPubMedCentralCrossRef
58.
go back to reference Springer SA, Di Paola A, Azar MM, Barbour R, Krishnan A, Altice FL. Extended-release naltrexone reduces alcohol consumption among released prisoners with HIV disease as they transition to the community. Drug Alcohol Depend. 2017;174:158–70.PubMedPubMedCentralCrossRef Springer SA, Di Paola A, Azar MM, Barbour R, Krishnan A, Altice FL. Extended-release naltrexone reduces alcohol consumption among released prisoners with HIV disease as they transition to the community. Drug Alcohol Depend. 2017;174:158–70.PubMedPubMedCentralCrossRef
59.
go back to reference Chokron Garneau H, Venegas A, Rawson R, Ray LA, Glasner S. Barriers to initiation of extended release naltrexone among HIV-infected adults with alcohol use disorders. J Subst Abuse Treat. 2018;85:34–7.PubMedCrossRef Chokron Garneau H, Venegas A, Rawson R, Ray LA, Glasner S. Barriers to initiation of extended release naltrexone among HIV-infected adults with alcohol use disorders. J Subst Abuse Treat. 2018;85:34–7.PubMedCrossRef
60.
go back to reference Chander G, Monroe AK, Crane HM, Hutton HE, Saag MS, Cropsey K, et al. HIV primary care providers–Screening, knowledge, attitudes and behaviors related to alcohol interventions. Drug Alcohol Depend. 2016;161:59–66.PubMedPubMedCentralCrossRef Chander G, Monroe AK, Crane HM, Hutton HE, Saag MS, Cropsey K, et al. HIV primary care providers–Screening, knowledge, attitudes and behaviors related to alcohol interventions. Drug Alcohol Depend. 2016;161:59–66.PubMedPubMedCentralCrossRef
61.
go back to reference Hu X, Harman J, Winterstein AG, Zhong Y, Wheeler AL, Taylor TN, et al. Utilization of Alcohol Treatment among HIV-Positive women with Hazardous drinking. J Subst Abuse Treat. 2016;64:55–61.PubMedPubMedCentralCrossRef Hu X, Harman J, Winterstein AG, Zhong Y, Wheeler AL, Taylor TN, et al. Utilization of Alcohol Treatment among HIV-Positive women with Hazardous drinking. J Subst Abuse Treat. 2016;64:55–61.PubMedPubMedCentralCrossRef
62.
go back to reference Conen A, Fehr J, Glass TR, Furrer H, Weber R, Vernazza P, et al. Self-reported alcohol consumption and its association with adherence and outcome of antiretroviral therapy in the Swiss HIV Cohort Study. Antivir Ther. 2009;14:349–57.PubMedCrossRef Conen A, Fehr J, Glass TR, Furrer H, Weber R, Vernazza P, et al. Self-reported alcohol consumption and its association with adherence and outcome of antiretroviral therapy in the Swiss HIV Cohort Study. Antivir Ther. 2009;14:349–57.PubMedCrossRef
63.
go back to reference Gurung S, Ventuneac A, Cain D, Mirzayi C, Ferraris C, Rendina HJ, et al. Alcohol and substance use diagnoses among HIV-positive patients receiving care in NYC clinic settings. Drug Alcohol Depend. 2017;180:62–7.PubMedPubMedCentralCrossRef Gurung S, Ventuneac A, Cain D, Mirzayi C, Ferraris C, Rendina HJ, et al. Alcohol and substance use diagnoses among HIV-positive patients receiving care in NYC clinic settings. Drug Alcohol Depend. 2017;180:62–7.PubMedPubMedCentralCrossRef
64.
go back to reference Breslow RA, Castle I-JP, Chen CM, Graubard BI. Trends in Alcohol Consumption among Older americans: National Health Interview Surveys, 1997 to 2014. Alcohol Clin Exp Res. 2017;41:976–86.PubMedPubMedCentralCrossRef Breslow RA, Castle I-JP, Chen CM, Graubard BI. Trends in Alcohol Consumption among Older americans: National Health Interview Surveys, 1997 to 2014. Alcohol Clin Exp Res. 2017;41:976–86.PubMedPubMedCentralCrossRef
65.
67.
go back to reference Woods AJ, Porges EC, Bryant VE, Seider T, Gongvatana A, Kahler CW, et al. Current heavy alcohol consumption is Associated with Greater Cognitive Impairment in older adults. Alcohol Clin Exp Res. 2016;40:2435–44.PubMedPubMedCentralCrossRef Woods AJ, Porges EC, Bryant VE, Seider T, Gongvatana A, Kahler CW, et al. Current heavy alcohol consumption is Associated with Greater Cognitive Impairment in older adults. Alcohol Clin Exp Res. 2016;40:2435–44.PubMedPubMedCentralCrossRef
68.
go back to reference Gebre BB. Factors Associated with Alcohol Use Disorder among people living with HIV/AIDS attending Art Clinic, Mizan Tep University Teaching Hospital, South West Ethiopia. HIV AIDS (Auckl). 2019;11:239–45.PubMed Gebre BB. Factors Associated with Alcohol Use Disorder among people living with HIV/AIDS attending Art Clinic, Mizan Tep University Teaching Hospital, South West Ethiopia. HIV AIDS (Auckl). 2019;11:239–45.PubMed
69.
go back to reference Soboka M, Tesfaye M, Feyissa GT, Hanlon C. Alcohol use disorders and associated factors among people living with HIV who are attending services in South West Ethiopia. BMC Res Notes. 2014;7:828.PubMedPubMedCentralCrossRef Soboka M, Tesfaye M, Feyissa GT, Hanlon C. Alcohol use disorders and associated factors among people living with HIV who are attending services in South West Ethiopia. BMC Res Notes. 2014;7:828.PubMedPubMedCentralCrossRef
70.
go back to reference Veld DHI, ’t, Pengpid S, Colebunders R, Skaal L, Peltzer K. High-risk alcohol use and associated socio-demographic, health and psychosocial factors in patients with HIV infection in three primary health care clinics in South Africa. Int J STD AIDS. 2017;28:651–9.PubMedCrossRef Veld DHI, ’t, Pengpid S, Colebunders R, Skaal L, Peltzer K. High-risk alcohol use and associated socio-demographic, health and psychosocial factors in patients with HIV infection in three primary health care clinics in South Africa. Int J STD AIDS. 2017;28:651–9.PubMedCrossRef
71.
go back to reference Crane HM, McCaul ME, Chander G, Hutton H, Nance RM, Delaney JAC, et al. Prevalence and Factors Associated with Hazardous Alcohol Use among persons living with HIV across the US in the current era of antiretroviral treatment. AIDS Behav. 2017;21:1914–25.PubMedPubMedCentralCrossRef Crane HM, McCaul ME, Chander G, Hutton H, Nance RM, Delaney JAC, et al. Prevalence and Factors Associated with Hazardous Alcohol Use among persons living with HIV across the US in the current era of antiretroviral treatment. AIDS Behav. 2017;21:1914–25.PubMedPubMedCentralCrossRef
72.
go back to reference Matson TE, McGinnis KA, Rubinsky AD, Frost MC, Czarnogorski M, Bryant KJ, et al. Gender and alcohol use: influences on HIV care continuum in a national cohort of patients with HIV. AIDS. 2018;32:2247–53.PubMedCrossRef Matson TE, McGinnis KA, Rubinsky AD, Frost MC, Czarnogorski M, Bryant KJ, et al. Gender and alcohol use: influences on HIV care continuum in a national cohort of patients with HIV. AIDS. 2018;32:2247–53.PubMedCrossRef
73.
go back to reference Gnatienko N, Calver K, Sullivan M, Forman LS, Heeren T, Blokhina E, et al. Heavy alcohol use among women and men living with HIV in Uganda, Russia, and the United States. J Stud Alcohol Drugs. 2021;82:486–92.PubMedPubMedCentralCrossRef Gnatienko N, Calver K, Sullivan M, Forman LS, Heeren T, Blokhina E, et al. Heavy alcohol use among women and men living with HIV in Uganda, Russia, and the United States. J Stud Alcohol Drugs. 2021;82:486–92.PubMedPubMedCentralCrossRef
74.
go back to reference Grant BF, Chou SP, Saha TD, Pickering RP, Kerridge BT, Ruan WJ, et al. Prevalence of 12-Month Alcohol Use, High-Risk drinking, and DSM-IV Alcohol Use Disorder in the United States, 2001–2002 to 2012–2013: results from the national epidemiologic survey on Alcohol and related conditions. JAMA Psychiatry. 2017;74:911–23.PubMedPubMedCentralCrossRef Grant BF, Chou SP, Saha TD, Pickering RP, Kerridge BT, Ruan WJ, et al. Prevalence of 12-Month Alcohol Use, High-Risk drinking, and DSM-IV Alcohol Use Disorder in the United States, 2001–2002 to 2012–2013: results from the national epidemiologic survey on Alcohol and related conditions. JAMA Psychiatry. 2017;74:911–23.PubMedPubMedCentralCrossRef
75.
go back to reference Leone AG, Trapani D, Schabath MB, Safer JD, Scout NFN, Lambertini M, et al. Cancer in transgender and gender-diverse persons: a review. JAMA Oncol. 2023;9:556–63.PubMedCrossRef Leone AG, Trapani D, Schabath MB, Safer JD, Scout NFN, Lambertini M, et al. Cancer in transgender and gender-diverse persons: a review. JAMA Oncol. 2023;9:556–63.PubMedCrossRef
76.
go back to reference Hughto JMW, Quinn EK, Dunbar MS, Rose AJ, Shireman TI, Jasuja GK. Prevalence and co-occurrence of Alcohol, Nicotine, and other Substance Use Disorder diagnoses among US Transgender and Cisgender adults. JAMA Netw Open. 2021;4:e2036512.PubMedPubMedCentralCrossRef Hughto JMW, Quinn EK, Dunbar MS, Rose AJ, Shireman TI, Jasuja GK. Prevalence and co-occurrence of Alcohol, Nicotine, and other Substance Use Disorder diagnoses among US Transgender and Cisgender adults. JAMA Netw Open. 2021;4:e2036512.PubMedPubMedCentralCrossRef
77.
go back to reference Somé NH, Shokoohi M, Shield KD, Wells S, Hamilton HA, Elton-Marshall T, et al. Alcohol and cannabis use during the COVID-19 pandemic among transgender, gender-diverse, and cisgender adults in Canada. BMC Public Health. 2022;22:452.PubMedPubMedCentralCrossRef Somé NH, Shokoohi M, Shield KD, Wells S, Hamilton HA, Elton-Marshall T, et al. Alcohol and cannabis use during the COVID-19 pandemic among transgender, gender-diverse, and cisgender adults in Canada. BMC Public Health. 2022;22:452.PubMedPubMedCentralCrossRef
78.
go back to reference Azagba S, Latham K, Shan L. Cigarette, smokeless tobacco, and alcohol use among transgender adults in the United States. Int J Drug Policy. 2019;73:163–9.PubMedCrossRef Azagba S, Latham K, Shan L. Cigarette, smokeless tobacco, and alcohol use among transgender adults in the United States. Int J Drug Policy. 2019;73:163–9.PubMedCrossRef
79.
go back to reference Heath K, Samji H, Nosyk B, Colley G, Gilbert M, Hogg RS, et al. Cohort profile: seek and treat for the optimal prevention of HIV/AIDS in British Columbia (STOP HIV/AIDS BC). Int J Epidemiol. 2014;43:1073–81.PubMedPubMedCentralCrossRef Heath K, Samji H, Nosyk B, Colley G, Gilbert M, Hogg RS, et al. Cohort profile: seek and treat for the optimal prevention of HIV/AIDS in British Columbia (STOP HIV/AIDS BC). Int J Epidemiol. 2014;43:1073–81.PubMedPubMedCentralCrossRef
80.
go back to reference Juwono S, Milloy M-J, Choi J, Fairbairn N, Nolan S, Socías ME. Opioid agonist treatment improves progression through the HIV cascade of care among people living with HIV who use unregulated opioids. AIDS. 2022;36:1429–36.PubMedCrossRef Juwono S, Milloy M-J, Choi J, Fairbairn N, Nolan S, Socías ME. Opioid agonist treatment improves progression through the HIV cascade of care among people living with HIV who use unregulated opioids. AIDS. 2022;36:1429–36.PubMedCrossRef
81.
go back to reference Reddon H, Fairbairn N, Grant C, Milloy M-J. Experiencing homelessness and progression through the HIV cascade of care among people who use drugs. AIDS. 2023;37:1431–40.PubMedCrossRef Reddon H, Fairbairn N, Grant C, Milloy M-J. Experiencing homelessness and progression through the HIV cascade of care among people who use drugs. AIDS. 2023;37:1431–40.PubMedCrossRef
82.
go back to reference Binswanger IA, Nowels C, Corsi KF, Glanz J, Long J, Booth RE, et al. Return to drug use and overdose after release from prison: a qualitative study of risk and protective factors. Addict Sci Clin Pract. 2012;7:3.PubMedPubMedCentralCrossRef Binswanger IA, Nowels C, Corsi KF, Glanz J, Long J, Booth RE, et al. Return to drug use and overdose after release from prison: a qualitative study of risk and protective factors. Addict Sci Clin Pract. 2012;7:3.PubMedPubMedCentralCrossRef
83.
go back to reference Pelissier B, Wallace S, O’Neil JA, Gaes GG, Camp S, Rhodes W, et al. Federal prison residential drug treatment reduces substance use and arrests after release. Am J Drug Alcohol Abuse. 2001;27:315–37.PubMedCrossRef Pelissier B, Wallace S, O’Neil JA, Gaes GG, Camp S, Rhodes W, et al. Federal prison residential drug treatment reduces substance use and arrests after release. Am J Drug Alcohol Abuse. 2001;27:315–37.PubMedCrossRef
84.
go back to reference Mulia N, Tam TW, Schmidt LA. Disparities in the use and quality of alcohol treatment services and some proposed solutions to narrow the gap. Psychiatr Serv. 2014;65:626–33.PubMedPubMedCentralCrossRef Mulia N, Tam TW, Schmidt LA. Disparities in the use and quality of alcohol treatment services and some proposed solutions to narrow the gap. Psychiatr Serv. 2014;65:626–33.PubMedPubMedCentralCrossRef
85.
go back to reference Choi NG, DiNitto DM. Alcohol use disorder and treatment receipt among individuals aged 50 years and older: other substance use and psychiatric correlates. J Subst Abuse Treat. 2021;131:108445.PubMedCrossRef Choi NG, DiNitto DM. Alcohol use disorder and treatment receipt among individuals aged 50 years and older: other substance use and psychiatric correlates. J Subst Abuse Treat. 2021;131:108445.PubMedCrossRef
86.
go back to reference Socias ME, Scheuermeyer FX, Cui Z, Mok WY, Crabtree A, Fairbairn N et al. Using a cascade of care framework to identify gaps in access to medications for alcohol use disorder in British Columbia, Canada. Addiction. 2023. Socias ME, Scheuermeyer FX, Cui Z, Mok WY, Crabtree A, Fairbairn N et al. Using a cascade of care framework to identify gaps in access to medications for alcohol use disorder in British Columbia, Canada. Addiction. 2023.
87.
go back to reference Bharat C, Webb P, Wilkinson Z, McKetin R, Grebely J, Farrell M et al. Agreement between self-reported illicit drug use and biological samples: a systematic review and meta-analysis. Addiction. 2023. Bharat C, Webb P, Wilkinson Z, McKetin R, Grebely J, Farrell M et al. Agreement between self-reported illicit drug use and biological samples: a systematic review and meta-analysis. Addiction. 2023.
88.
go back to reference Rahm-Knigge RL, Norris AL, Dunsiger S. The moderating effects of alcohol use on the association between sexual orientation and HIV testing: results from the 2013–2018 National Health interview study. AIDS Care. 2023;35:1299–305.PubMedCrossRef Rahm-Knigge RL, Norris AL, Dunsiger S. The moderating effects of alcohol use on the association between sexual orientation and HIV testing: results from the 2013–2018 National Health interview study. AIDS Care. 2023;35:1299–305.PubMedCrossRef
89.
go back to reference Newcomb ME, Hill R, Buehler K, Ryan DT, Whitton SW, Mustanski B. High Burden of Mental Health Problems, Substance Use, Violence, and related psychosocial factors in Transgender, Non-binary, and gender diverse youth and young adults. Arch Sex Behav. 2020;49:645–59.PubMedCrossRef Newcomb ME, Hill R, Buehler K, Ryan DT, Whitton SW, Mustanski B. High Burden of Mental Health Problems, Substance Use, Violence, and related psychosocial factors in Transgender, Non-binary, and gender diverse youth and young adults. Arch Sex Behav. 2020;49:645–59.PubMedCrossRef
90.
go back to reference Sohler NL, Li X, Cunningham CO. Gender disparities in HIV Health Care utilization among the severely disadvantaged: can we determine the reasons? AIDS Patient Care STDS. 2009;23:775–83.PubMedPubMedCentralCrossRef Sohler NL, Li X, Cunningham CO. Gender disparities in HIV Health Care utilization among the severely disadvantaged: can we determine the reasons? AIDS Patient Care STDS. 2009;23:775–83.PubMedPubMedCentralCrossRef
91.
go back to reference Mayer KH, Grinsztejn B, El-Sadr WM. Transgender people and HIV Prevention: what we know and what we need to know, a call to action. J Acquir Immune Defic Syndr. 2016;72:S207–9.PubMedPubMedCentralCrossRef Mayer KH, Grinsztejn B, El-Sadr WM. Transgender people and HIV Prevention: what we know and what we need to know, a call to action. J Acquir Immune Defic Syndr. 2016;72:S207–9.PubMedPubMedCentralCrossRef
Metadata
Title
Prevalence and Correlates of Heavy Alcohol use among People Living with HIV who use Unregulated Drugs in Vancouver, Canada
Authors
Jeremy Hui
Hudson Reddon
Nadia Fairbairn
JinCheol Choi
M-J Milloy
Maria Eugenia Socias
Publication date
25-04-2024
Publisher
Springer US
Published in
AIDS and Behavior
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-024-04341-y
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Webinar | 06-02-2024 | 20:00 (CET)

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by: Viatris

Developed by: Springer Healthcare